In 2016 GSK Pharmaceuticals plans to invest a sum similar to that invested in previous years into research and development, including into clinical trials of new drugs and vaccines. In 2015 it had invested CZK 186m. This was stated for ČIANEWS by general manager Monika Horníková, who added that GSK wants to focus on recruiting students and older generations of physicians. The aim is also to strengthen inclusion and age diversity among employees. The company will also introduce to the market an innovative product to treat HIV and two products to treat respiratory illnesses.